ASX Share rice
Fri 14 May 2021 - 09:11:pm (Sydney)

AC8 Share Price

AUSCANN GROUP HOLDINGS LTDAC8Pharmaceuticals, Biotechnology & Life Sciences

AC8 Company Information

Name:

AusCann Group Holdings Ltd

Sector:

Healthcare

Industry:

Drug Manufacturers-Specialty & Generic

GIC Industry:

Pharmaceuticals

GIC Sub Industry:

Pharmaceuticals

Address:

35 Havelock Street West Perth WA Australia 6005

Phone:

61 8 6305 0705

Chief Exec. Officer:

Mr. Layton Patrick Mills

CFO & Head of Supply:

Mr. Charles Altshuler

Joint Company Sec.:

Ms. Susan Patricia Park FCIS, BCom, F Fin, ACA, AGIA, FFin, GAICD, ACIS, A

Company Overview:

AusCann Group Holdings Ltd, a pharmaceutical company, researches, develops, cultivates, produces, and distributes cannabinoid-based pharmaceuticals in Australia and internationally. It offers hard-shell capsules using Neuvis technology for the treatment of chronic neuropathic pain. The company is based in West Perth, Australia.

AC8 Share Price Information

Shares Issued:

317.05M

Market Capitalisation:

$36.46M

Revenue (TTM):

$1.27M

Revenue Per Share (TTM):

$0

Earnings per Share:

$-0.025

Operating Margin (TTM):

$-6.35

Return On Assets (TTM):

$-0.14

Return On Equity (TTM):

$-0.24

Quarterly Revenue Growth (YOY):

-0.77

Gross Profit(TTM):

$-1,498,952

Diluted Earnings Per Share (TTM):

$-0.026

AC8 CashFlow Statement

CashFlow Date:

2020-06-30

Investments:

$-5,559,268

Change To Liabilities:

$-631,862

Total Cashflow From Investing Activities:

$-5,559,268

Net Borrowings:

$-42,348

Net Income:

$-7,076,213

Total Cash From Operating Activities:

$-10,550,511

Depreciation:

$94.78K

Other Cashflow From Investing Activities:

$-219,909

Change To Inventory:

$-3,607,570

Change To Account Receivables:

$-53,797

Sale Purchase Of Stock:

$10.50K

Capital Expenditures:

$5.34M

AC8 Income Statement

Income Date:

2020-06-30

Income Before Tax:

$-7,076,210

Net Income:

$-7,076,210

Gross Profit:

$386.33K

Operating Income:

$-7,076,220

Other Operating Expenses:

$613.95K

Total Revenue:

$388.53K

Cost Of Revenue:

$2.20K

AC8 Balance Sheet

Balance Sheet Date:

2020-06-30

Total Liabilities:

$829.22K

Total Stockholder Equity:

$34.64M

Other Current Liabilities:

$98.36K

Total Assets:

$35.47M

Common Stock:

$75.47M

Other Current Assets:

$869.07K

Retained Earnings:

$-42,105,988

Other Assets:

$-1

Cash:

$19.17M

Total Current Liabilities:

$774.78K

Property - Plant & Equipment:

$11.82M

Net Tangible Assets:

$34.64M

Total Current Assets:

$23.64M

Net Receivables:

$1.33K

Short-Term Investments:

$11.82M

Inventory:

$3.61M

Accounts Payable:

$496.77K

Short-Term Investments:

$11.82

Non Current Liabilities Total:

$54.43K

AC8 Share Price History

AC8 News

21 Oct, 2020
There's no doubt that money can be made by owning shares of unprofitable businesses. For example, although Amazon.com...